Table 1.
Animal characteristics.
| Experimental Group | Animal ID | MHC Class I Alleles a | Age (Years) b | Sex |
|---|---|---|---|---|
| Mamu-B*08+ Vaccinees | r08014 | Mamu-A*01, Mamu-A*02, Mamu-B*08 | 13.6 | M |
| r14065 | Mamu-B*08 | 8.1 | F | |
| r16007 | Mamu-B*08 | 6.1 | F | |
| r17017 | Mamu-A*01, Mamu-B*08 | 4.8 | M | |
| r17115 | Mamu-B*08 | 4.4 | M | |
| rh2932 | Mamu-B*08 | 6.4 | F | |
| rh2943 | Mamu-B*08 | 7.1 | F | |
| rh3006 | Mamu-A*02, Mamu-B*08 | 5.3 | F | |
| rh3011 | Mamu-A*01, Mamu-B*08 | 4.6 | F | |
| rh3032 | Mamu-B*08 | 4.9 | M | |
| rh3033 | Mamu-A*02, Mamu-B*08 | 4.9 | M | |
| rh3036 | Mamu-B*08 | 4.8 | F | |
| rh3037 | Mamu-B*08 | 4.9 | F | |
| rh3045 | Mamu-B*08 | 5.2 | M | |
| rh3048 | Mamu-B*08 | 4.9 | F | |
| rh3053 | Mamu-B*08 | 5.3 | M | |
| Mamu-B*08+ Unvaccinated Controls | r12048 | Mamu-B*08 | 9.6 | M |
| r14010 | Mamu-B*08 | 8.1 | M | |
| r14095 | Mamu-B*08 | 7.4 | F | |
| r15057 | Mamu-B*08 | 6.9 | M | |
| r15058 | Mamu-A*02, Mamu-B*08 | 6.3 | M | |
| r15093 | Mamu-B*08 | 5.8 | F | |
| r16003 | Mamu-B*08 | 6.0 | F | |
| r17039 | Mamu-B*08 | 4.7 | F | |
| r17082 | Mamu-B*08 | 5.1 | F | |
| r17100 | Mamu-B*08 | 4.8 | M | |
| r17103 | Mamu-B*08 | 4.2 | M | |
| r18066 | Mamu-B*08 | 4.2 | F | |
| r18067 | Mamu-B*08 | 3.4 | F | |
| rh2494 | Mamu-B*08 | 16.2 | M | |
| rh2504 | Mamu-A*01, Mamu-B*08 | 14.1 | M | |
| rh2527 | Mamu-B*08 | 16.7 | F | |
| Mamu-B*08– Unvaccinated Controls | r05035 | Mamu-A*02 | 16.0 | F |
| rh2756 | Mamu-A*01 | 17.0 | F | |
| rh2810 | Mamu-A*01 | 12.1 | F | |
| rh2848 | Mamu-A*02 | 7.6 | M | |
| rh2861 | 9.5 | M | ||
| rh2995 | Mamu-A*01 | 4.6 | M | |
| rh3000 | Mamu-A*02 | 4.4 | M | |
| rh3013 | Mamu-A*02 | 4.4 | F |
a
MHC class I alleles relevant for spontaneous control of SIVmac239 viremia and/or characterization of SIVmac239-specific CTL populations.
b
Age at time of infecting SIVmac239 challenge.